Provectus Announces Preliminary Phase 2 Data For PH-10 In Its Psoriasis And Atopic Dermatitis Trials

Links shared publicly online about this topic.

  • 1,558
    total visits

Provectus Announces Preliminary Phase 2 Data For PH-10 In Its Psoriasis And Atopic Dermatitis Trials

medicalnewstoday.com —

Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced preliminary data for the company's PH-10 Phase 2 clinical trial fo

View full resource at medicalnewstoday.com

Tags: Allergies, Eczema, Dermatology, Psoriasis, Pharma, Phase 2 Clinical Trial, Clinical Trial, Oncology

  • Share

Most Recently Shared on December 3, 2009 at 7:35 am By:

mnt_eczema MNT Eczema News

Provectus Announces Preliminary Phase 2 Data For PH-10 In Its Psoriasis And Atopic Dermatitis Trials: Provectus Pha... http://bit.ly/7iLIRK

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Clinical Trials MNT Clinical Trials

MNT Dermatology News MNT Dermatology News

Advertisement